Elevation Oncology Inc. Gains 29.25%

Fri, Jan 12, 2024 at 07:38 PM

Elevation Oncology Inc. (ELEV:NASDAQ) jumped higher at $2.74, representing a gain of 29.2%. On Fri, Jan 12, 2024, ELEV:NASDAQ touched a New 2-Week High of $2.74. The stock appeared on our News Catalysts scanner on Tue, Jan 09, 2024 at 02:07 PM in the 'BIOTECH' category. From Tue, Jan 02, 2024, the stock recorded 62.50% Up Days and 77.78% Green Days

About Elevation Oncology Inc. (ELEV:NASDAQ)

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations.

Top 10 Gainers:

Applied UV Inc. (AUVI:NASDAQ), 67.11%
Atreca, Inc. (BCEL:NASDAQ), 52.63%
SRIVARU Holding Limited (SVMH:NASDAQ), 46.21%
Vinco Ventures Inc. (BBIG:NASDAQ), 42.86%
SYLA Technologies Co. Ltd. (SYT:NASDAQ), 36.1%
Entera Bio Ltd. (ENTX:NASDAQ), 35.17%
Nubia Brand International Corp. (NUBI:NASDAQ), 33.4%
Cyclo Therapeutics Inc. (CYTH:NASDAQ), 30.99%
Nuburu Inc. (BURU:NYSEMKT), 29.25%
Elevation Oncology Inc. (ELEV:NASDAQ), 29.25%